Results 261 to 270 of about 26,112,494 (338)

Stratum Corneum Interleukin-2 in Facial Eczema at 1-Month-Old Predicts Later Atopic Dermatitis. [PDF]

open access: yesAllergy
Maehara E   +14 more
europepmc   +1 more source

Evaluating Interleukin-2 and Its Receptors As Indicators of Acute Renal Graft Rejection. [PDF]

open access: yesCureus
Gompou A   +7 more
europepmc   +1 more source

[<sup>68</sup>Ga]Ga-interleukin-2 for imaging activated T-lymphocytes: biochemical characterization and phase I study in normal subjects. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Signore A   +7 more
europepmc   +1 more source

Interleukin-2–based therapies in cancer

Science Translational Medicine, 2022
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the development of improved IL-2 formulations with IL-2 receptor bias and tissue-targeting properties.
M. E. Raeber, Dilara Şahin, O. Boyman
semanticscholar   +1 more source

The Interleukin -2

Acta Clinica Belgica, 1987
SummaryDiscovered in 1976, the lymphokine interleukin-2, intensively studied during the last years, plays a major role in the regulation of the immune function. The authors reviewing its principal properties, anticipate forthcoming prospects of considerable implications in therapy.Acta Clin. Bclg. 42, 4: 255–68.
M, Hiden, P, Nève
openaire   +2 more sources

Interleukin 2 receptors

Leukemia Research, 1990
Interleukin 2 receptors (IL-2-R) are composed of (at least) two chains: the alpha chain (or p55 or Tac) and the beta chain (or p70 or p75). The association of both chains constitutes high affinity IL2-R complexes (Kd congruent to 10-100 pM), whereas the alpha-chain or the beta chain alone bind IL-2 with low (Kd congruent to 5-50 nM) and intermediate ...
M, Allouche   +5 more
openaire   +2 more sources

Recombinant Interleukin‐2

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
Recombinant interleukin (IL)‐2 is a newly approved immunoregulatory protein produced by lymphocytes that exhibits a wide range of immunologic effects. It is a true biologic response modifier in that is has no known direct antitumor activity, but mediates its cytotoxicity through activation of effector cells including T cells, natural killer cells, and ...
J K, Bruton, J M, Koeller
openaire   +2 more sources

Regulation of Interleukin 2 Receptor Expression by Interleukin 2

Scandinavian Journal of Immunology, 1986
The regulatory influence of Interleukin 2 (IL‐2) on the expression of IL‐2 receptors (IL.‐2R) was studied using long‐term cultured T‐cell lines and recombinant IL‐2 (r‐IL‐2). Three T‐cell lines with different growth requirements were used as model systems: insulin‐specific BK‐BI‐1.2 cells express IL‐2R transiently after antigenic restimulation ...
A B, Reske-Kunz   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy